CLOMID 50MG DIN 00018031
Status: Cancelled Post Market
Holder: MERRELL PHARMS INC., DIVISION OF MERRELL DOW (CAN)
Molecule: CLOMIPHENE CITRATE
Health Canada record
| Active ingredient(s) | CLOMIPHENE CITRATE 50 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | G03GB02 CLOMIFENE |
| Original market date | 31-Dec-1967 |
| Current status date | 09-Sep-1996 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing CLOMIPHENE CITRATE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02091879 | CLOMID | SANOFI-AVENTIS CANADA INC | Tablet | CLOMIPHENE CITRATE 50 MG | Cancelled Post Market |
| 00640158 | SEROPHENE TAB 50MG | PHARMASCIENCE INC | Tablet | CLOMIPHENE CITRATE 50 MG | Cancelled Post Market |
| 00893722 | SEROPHENE TAB 50MG | EMD SERONO, A DIVISION OF EMD INC., CANADA | Tablet | CLOMIPHENE CITRATE 50 MG | Cancelled Post Market |
International API supply for CLOMIPHENE CITRATE
10 active FDA Drug Master Files.
Request a quote for CLOMID 50MG